1Harrison CN, Bareford D, Butt N, et al. Guideline for investiga- tion and management of adults and children presenting with a thrombocytosis [J]. Br J Haematol, 2010, 149 (3):352-375. doi: 10.1111/j.1365-2141.2010.08122.x. 被引量：1
2Barbui T, Barosi G, Birgegard G, et al. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet [J]. J Clin Oncol, 2011, 29 (6):761-770. doi: 10.1200/ JCO.2010.31.8436. 被引量：1
3Harrison CN, Butt N, Campbell P, et al. Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia [J]. Br J Haematol, 2014, 167 (3): 421-423. doi: 10.1111/bjh.12986. 被引量：1
4Vannucchi AM, Barbui T, Cervantes F, et al. Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J]. Ann Oncol, 2015, 26 Suppl 5:v85-99. doi: 10.1093/annonc/mdv203. 被引量：1
5Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127 (20):2391-2405. doi: 10.1182/blood-2016-03-643544. 被引量：1
6Besses C, Hemfindez-Boluda JC, Prez Encinas M, et al. Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi method[J]. Ann Hematol, 2016, 95 (5):719-732. doi: 10.1007/ s00277-016-2614-1. 被引量：1
7Barosi G, Mesa RA, Thiele J, et al. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment[J]. Leukemia, 2008, 22(2):437-438. doi:10.1038/sj. leu.2404914. 被引量：1
8Kvasnicka HM, Thiele J. Prodromal myeloproliferative neoplasms: the 2008 WHO classification [J]. Am J Hematol, 2010, 85( 1 ):62-69. doi: 10.1002/ajh.21543. 被引量：1
9Barbui T, Thiele J, Vannucchi AM, et al. Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primarymyelofibrosis versus essential thrombocythemia [J]. Leukemia, 2013, 27( 10):1953-1958. doi: 10.1038/leu.2013.74. 被引量：1
10Barosi G. Essential thrombocythemia vs. early/prefibrotic myelo- fibrosis: why does it matter [J]. Best Pract Res Clin Haematol, 2014, 27(2):129-140. doi: 10.1016/j.beha.2014.07.004. 被引量：1
